InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: None

Sunday, 08/27/2017 10:23:58 PM

Sunday, August 27, 2017 10:23:58 PM

Post# of 144814
Capricor Therapeutics and Aduro Biotech recently fails Janssen in both stem cell and pancreas cancer therapy trials.

Janssen now shows interest and attends multiple presentations for PharmaCyte's Cell-in-a-Box therapies; targeted therapies for cancer and diabetes.

NDA's were signed with big pharma: http://pharmacyte.com/pharmacyte-seeks-to-solve-pancreas.../
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News